The PennZone

FAYETTEVILLE, Ark. & AUCKLAND, New Zealand - PennZone -- Lineus Medical is pleased to announce a new distribution agreement with Venture Medical, a 100% New Zealand–owned medical supplier based in Auckland. Venture Medical specializes in vascular access and wound care and will now add Lineus Medical's SafeBreak® Vascular, the only breakaway device for IV lines clinically proven to reduce multiple IV complications, to its portfolio. This partnership expands SafeBreak's availability to hospitals and healthcare providers throughout New Zealand.

SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.¹ When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money¹. SafeBreak is cleared for all vascular lines down to two weeks of age both in the United Sates and Canada.

More on The PennZone

• $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
• Costa Oil – 10 Minute Oil Change Opens 70th Location in Reed City, MI
• New Book: Cold War Sci-Fi Thriller Arrives Today
• BeeCool Bikes Unveils Next-Generation "Super Frame" with Bee Defender Series
• DEADLINE TOMORROW: Berger Montague Advises Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) Investors to Inquire About a Securities Fraud Class Action by August 29, 2025

Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks a significant milestone in Lineus Medical's international growth. By partnering with Venture Medical, we are expanding SafeBreak Vascular into a new market and building momentum for broader global adoption. Venture Medical's local expertise and strong customer relationships make them the right partner to drive commercial success in New Zealand."

"Signing this agreement with Venture Medical is an important step in bringing SafeBreak Vascular to in the people of New Zealand.",  Vance Clement CEO of Lineus Medical stated.  "Our mission is to reduce the "pains" associated with medical lines and make SafeBreak the standard of care globally."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications¹. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.

More on The PennZone

• University of South Pacific and Battery Pollution Technologies Forge Strategic Partnership to tackle Battery End-of-Life Challenges in the Pacific
• Shincheonji Tanzania Church Holds Revelation Bible Exam with Local Pastors and Believers
• Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
• Growth Acceleration via Strategic Reverse Split After $10 Million Acquisition for Concerts.com and TicketStub.com; AI Powered Sports/Entertainment Co
• Hollywood Casting Director's Book Hits #1 on Amazon Before Release

References

1.      Data on file